CB2 Insights Partners With FCM Global To Help Medical Marijuana R&D In Colombia

CB2 Insights (CSE:CBII) (OTC: CBIIF) has partnered with a Colombian cannabis company, FCM Global.

The collaboration will aim to help the deployment of future FCM CBD-based products, and both companies will try to create a foundation for future clinical trials and product innovations in Colombia.

Medical marijuana is still not legally available in the country, despite of having more than $400 million of total investments since 2019, and fulfilling other requirements needed to create an “ideal market for that investment” such as geography, climate, affordable labor …

Full story available on Benzinga.com

More CB2 Insights Partners With FCM Global To Help Medical Marijuana R&D In Colombia